Abstract | BACKGROUND: OBJECTIVE: To evaluate prognostic and predictive significance of tumor TS protein level in NSCLC. METHODS: Electronic searches were performed for relevant studies in PubMed, EMBASE, Web of Science, and Chinese Biomedical Literature Database. Hazard ratios (HRs) for overall survival (OS) and progression-free survival (PFS) were pooled for meta-analysis. Subgroup and sensitivity analyses were performed. Publication bias was evaluated by funnel plot and Begg's test. RESULTS: Twenty-four studies, including 2280 patients, were eligible. This analysis showed that patients with low TS expression had statistically significantly longer OS and PFS than those with high TS (HR=0.51 and HR=0.49, respectively). Based on TS-targeted drug use status, TS expression was significantly associated with OS in pemetrexed (HR=0.42) and 5-Fluorouracil subgroups (HR=0.34), but not in no TS-targeted drug subgroup. There were similar results for PFS analyses. Sensitivity analysis indicated that the results were robust. Begg's test did not reveal any publication bias. CONCLUSION: Low TS protein expression is a favorable predictive factor for better OS/PFS in NSCLC patients treated with TS-targeted drugs. Prognostic value of TS protein expression needs further validation.
|
Authors | Qingyun Liu, Zubin Yu, Ying Xiang, Na Wu, Long Wu, Bin Xu, Liang Wang, Ping Yang, Yafei Li, Li Bai |
Journal | Cancer biomarkers : section A of Disease markers
(Cancer Biomark)
Vol. 15
Issue 1
Pg. 65-78
( 2015)
ISSN: 1875-8592 [Electronic] Netherlands |
PMID | 25524944
(Publication Type: Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't, Review, Systematic Review)
|
Chemical References |
|
Topics |
- Carcinoma, Non-Small-Cell Lung
(enzymology, pathology)
- Disease-Free Survival
- Humans
- Lung Neoplasms
(enzymology, pathology)
- Prognosis
- Survival Analysis
- Thymidylate Synthase
(metabolism)
|